On May 28, 2025, TELA Bio, Inc. held its Annual Meeting where stockholders approved significant changes to the company's Equity Incentive Plan, including increasing authorized shares by 3.5 million and modifying the governing structure. Additionally, directors were elected and KPMG was ratified as the public accountant for 2025.